Paul W. Hoelscher is CFO & VP at Horizon Therapeutics Public Ltd Co (HZNP). They have made 10 open-market trades across 1 company since 2019, most recently 2022-04-20.
CIK 0001611468
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HZNP | 22,591 | $2.6M |
Shares reported on the most recent Form 4, priced at the 2022-04-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HZNP | SELL | 2022-04-20 | 2022-04-22 | $114.71 | $11.5M | -9.1% | -17.0% | -20.3% |
| HZNP | SELL | 2022-04-06 | 2022-04-08 | $110.01 | $67.6M | -2.5% | -26.5% | -26.2% |
| HZNP | SELL | 2022-03-23 | 2022-03-25 | $110.00 | $5.7M | -0.3% | -2.3% | -24.1% |
| HZNP | SELL | 2021-12-28 | 2021-12-30 | $110.00 | $943K | -11.5% | -13.9% | -2.4% |
| HZNP | SELL | 2021-05-14 | 2021-05-14 | $90.01 | $18.5M | +2.6% | +1.4% | +17.0% |
| HZNP | SELL | 2020-08-24 | 2020-08-25 | $75.76 | $4.5M | -2.9% | +2.3% | -4.9% |
| HZNP | SELL | 2020-05-05 | 2020-05-07 | $38.00 | $4.0M | +11.0% | +17.7% | +83.5% |
| HZNP | SELL | 2019-10-15 | 2019-10-17 | $28.01 | $560K | +2.3% | +7.7% | +32.3% |
| HZNP | SELL · 10b5-1 | 2019-08-30 | 2019-09-04 | $28.00 | $38K | -2.9% | -1.3% | +20.4% |
| HZNP | SELL | 2019-08-21 | 2019-08-23 | $28.01 | $398K | -2.4% | +0.2% | +13.4% |
| HZNP | SELL | 2019-08-21 | 2019-08-23 | $28.00 | $2.0M | -2.4% | +0.2% | +13.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.